These data further suggested that Brg1, as a downstream oncogenic substrate of FBW7, might participate in the promotion of tumor progression and tumor metastasis caused by reduced FBW7 expression in gastric cancer setting. This evidence concerns the gene SMARCA4 and neoplasm.